Chloë Hardern

2PUBLICATIONS

0CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Jun 10, 2024

Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy.

Jonathan Salcedo, Daniel Hill-McManus, Chloë Hardern

Pageof 1

Frequent Collaborators

Frequent Collaborators